Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Sales/Maturities of Investments

$14.50M

Quarterly · Period ending: · USD

LCTX logo

LCTX Sales/Maturities of Investments

Latest reported$14.50M
LCTX Quarterly Sales/Maturities of Investments ($0.00 → $14.50M)
High-resolution chart · PNG

LCTX sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,000,000
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.